跳至主要内容
临床试验/JPRN-jRCTs041180144
JPRN-jRCTs041180144已完成2 期

A Phase II Study of Chemotherapy Combined with Tyrosine Kinase Inhibitors for Children with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia - JPLSG-ALL-Ph13

Sato Atsushi0 个研究点目标入组 43 人开始时间: 2019年3月29日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
Sato Atsushi
入组人数
43

研究概览

简要总结

The ALL-Ph13 was the first trial for Japanese children with Philadelphia chromosome-positive ALL in which TKIs were continuously administered with chemotherapy. Despite the limited use of SCT, this study showed more than 60% of the 3-year EFS. After the amendment of the protocol, the toxicities of the ALL-Ph13 were acceptable. The ALL-Ph13 showed comparable outcomes to other clinical trials using TKIs with chemotherapy.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 1age old 至 <= 19age old(—)
性别
All

入选标准

  • 1) diagnosis of Ph+ALL
  • 2) age between 1 and 19 years old
  • 3) ECOG performance status (PS) score of 0-3
  • 4) no history of previous chemotherapy or radiation therapy
  • 5) written informed consent obtained from patient or guardians.

排除标准

  • 1) uncontrolled infection, including active tuberculosis and positive of HIV antibody.
  • 2) pregnancy or high possibility of pregnancy and giving suck wiman.
  • 3) history of congenital or acquired immunodeficiency.
  • 4) any inappropriate status judged by

研究者

发起方
Sato Atsushi

相似试验

已完成
2 期
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) ALL-B12: A Multi-Center Phase II/III Study in Children with Newly Diagnosed B-cell Precursor Acute Lymphoblastic LeukemiaB cell precursor Acute Lymphoblastic Leukemia
JPRN-UMIN000009339Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)1,940
已完成
2 期
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-D05: Phase II Study of Risk Stratified Multi-drug Chemotherapy on Down Syndrome with Newly diagnosed Childhood Acute Myeloid LeukemiaAcute myeloid Leukemia Myelodysplastic syndrome
JPRN-UMIN000000989Japanese Pediatric Leukemia/Lymphoma Study Group(JPLSG)73
已完成
不适用
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) CML-08: A Multi-Center Observational Study for Children with Chronic Phase of Chronic Myeloid LeukemiaChronic Phase of Chronic Myeloid Leukemia (CML) in children
JPRN-UMIN000002581Japanese Pediatric Leukemia/Lymphoma Study Group22
招募中
2 期
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) ALL-T11 and Japan Adult Leukemia Study Group (JALSG) T-ALL-211-U ALL-T11: A Multi-Center Phase II Study in Children and Adolescence with Newly Diagnosed T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic Leukemia
JPRN-UMIN000006851Japanese Pediatric Leukemia/Lymphoma Study Group147
已完成
2 期
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-R11: Multi-center Phase II Study of the efficacy and the safety in the induction chemotherapy containing fludarabine for children with the first bone marrow relapse and induction failure of acute myeloid leukemia.acute myeloid leukemia
JPRN-UMIN000007390Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)50